This book aims to address the major aspects of future drug product development and therapy for older adults, giving practical guidance for the rational product and clinical development and prescribing of drug products to this ever growing segment of the population. With authors coming from key "aging" markets such as Europe, the USA, China and Japan, the book will provide valuable information for students, scientists, regulators, practitioners, and other healthcare professionals from academia, industry and regulatory bodies.
Publisher: Springer International Publishing AG
Number of pages: 771
Weight: 1712 g
Dimensions: 235 x 155 x 41 mm
Edition: 1st ed. 2016
"This book reviews a wide range of topics related to drug development for an aging population ... . The intended audience includes practitioners and/or researchers interested in sharing multidisciplinary knowledge, research, and practice expertise to fill existing knowledge gaps in order to improve drug product development for older, very old, multimorbid, and frail individuals." (Susan K. Romann, Doody's Book Reviews, February, 2017)